Klinface-A Gel is a topical dermatological formulation containing Adapalene 0.1% w/w and Clindamycin 1% w/w, indicated for the treatment of acne vulgaris. Adapalene, a third-generation synthetic retinoid, modulates cellular differentiation and keratinization, thereby preventing the formation of microcomedones and promoting the normalization of follicular epithelial desquamation. Clindamycin, a lincosamide antibiotic, exhibits bacteriostatic activity against Propionibacterium acnes by inhibiting bacterial protein synthesis, reducing inflammation and bacterial colonization within the pilosebaceous unit. The combination of these active ingredients addresses both the inflammatory and comedonal components of acne, enhancing therapeutic efficacy compared to monotherapy. Klinface-A Gel is applied once daily to the affected areas after cleansing, typically in the evening. Common adverse effects may include mild erythema, dryness, peeling, and transient burning or stinging sensations at the application site, which usually subside with continued use. Patients are advised to avoid excessive sun exposure and use sunscreen during treatment. This product is contraindicated in individuals with hypersensitivity to adapalene, clindamycin, or any formulation excipients. Clinical use should be guided by a healthcare professional to optimize outcomes and minimize adverse reactions.